<?xml version="1.0" encoding="UTF-8"?>
<p id="para30">In general, vaccine development from discovery to licensure can cost billions of dollars, can take over 10 years to complete, and has an average 94% chance of failure.
 <xref rid="bib6" ref-type="bibr">
  <sup>6</sup>
 </xref> Where national health security concerns exist, whether due to naturally emerging disease or bioterrorism-related threats, governments such as those of the USA, the UK, France, and Germany invest in research and development even if global markets are extremely small, as the cases of Ebola and other African viral haemorrhagic fevers have shown.
 <xref rid="bib7" ref-type="bibr">
  <sup>7</sup>
 </xref> However, worldwide investments in epidemic infectious disease are small.
 <xref rid="bib8" ref-type="bibr">
  <sup>8</sup>
 </xref>
</p>
